Form 8-K - Current report:
SEC Accession No. 0001009919-06-000019
Filing Date
2006-07-10
Accepted
2006-07-10 16:47:23
Documents
2
Period of Report
2006-07-07
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 AMERSIN FORM 8-K ITEM 4.02 f060710amls8k.htm 8-K 12850
2 f060710amls8k002.gif GRAPHIC 1060
  Complete submission text file 0001009919-06-000019.txt   16252
Mailing Address 410 PARK AVENUE 15TH FLOOR NEW YORK NY 10022
Business Address FLOOR 23, CHANGJIANG BUILDING, 1 MINQUAN ROAD, JIANGHAN DISTRICT WUHAN CITY F4 430021 604-881-2899
Amersin Life Sciences CORP (Filer) CIK: 0001009919 (see all company filings)

IRS No.: 880419476 | State of Incorp.: NV | Fiscal Year End: 0131
Type: 8-K | Act: 34 | File No.: 000-25553 | Film No.: 06954352
SIC: 2834 Pharmaceutical Preparations